Caribou Biosciences Newsroom

Caribou Biosciences, Inc. (NASDAQ:CRBU) Surges 25% Yet Its Low P/S Is No Reason For Excitement

Simply Wall StNov 5 06:00 ET

Caribou Wins Pilot Competition With Right at Home, Becoming National Preferred Partner for Rewards & Recognition Across the United States

BusinesswireNov 1 10:00 ET

Is Caribou Biosciences (CRBU) a Promising Gene Editing Stock?

Yahoo FinanceOct 31 03:53 ET

Caribou Coffee's Holiday Menu Introduces Energizing Cranberry Beverages and Festive Favorites

PR NewswireOct 30 12:08 ET

Q3 Pharma and Biotech Layoffs in Charts: More Than 1000 Each in July and August

Seeking AlphaOct 4 14:02 ET

Caribou Biosciences to Present Preclinical Data Supporting Development of CB-010 for Lupus at the American College of Rheumatology Convergence 2024

Yahoo FinanceSep 25 09:00 ET

With 60% Ownership, Caribou Biosciences, Inc. (NASDAQ:CRBU) Boasts of Strong Institutional Backing

Yahoo FinanceSep 18 07:34 ET

Vir Biotechnology Names Jason O'Byrne Finance Chief

MT NewswiresSep 10 08:55 ET

Truist Financial Initiates Caribou Biosciences(CRBU.US) With Buy Rating

Moomoo NewsSep 4 07:31 ET · Ratings

Caribou Biosciences Announces CFO Resignation and Succession Plan

TipRanksSep 3 16:30 ET

Express News | Caribou Biosciences- Plans to Appoint Ryan Fischesser to Assume Role of Principal Accounting Officer, Effective as Close of Business on Sept 27

ReutersSep 3 16:03 ET

Express News | Caribou Biosciences Inc - on Sept 1 Jason O'byrne, CFO, Informed of Intent to Resign From Position

ReutersSep 3 16:02 ET

Express News | Caribou Biosciences Inc: CB-010 Gallop Phase 1 Trial in Patients With Ln and Erl Is on Track to Initiate by Ye 2024

ReutersSep 3 08:04 ET

Express News | Caribou Biosciences Announces the FDA Has Granted Fast Track Designations to CB-010 in Refractory Sle and to CB-012 in Relapsed or Refractory Aml

ReutersSep 3 08:00 ET

Caribou Biosciences Announces the FDA Has Granted Fast Track Designations to CB-010 in Refractory SLE and to CB-012 in Relapsed or Refractory AML

GlobeNewswireSep 3 08:00 ET

Caribou Biosciences to Participate in Upcoming Investor Conferences

GlobeNewswireAug 26 16:00 ET

Caribou Coffee Brings a Taste of the Apple Orchard to Its New Fall Menu

PR NewswireAug 19 10:15 ET

H.C. Wainwright Maintains Caribou Biosciences(CRBU.US) With Buy Rating, Maintains Target Price $9

Moomoo NewsAug 14 07:31 ET · Ratings

Express News | HC Wainwright & Co. Reiterates Buy on Caribou Biosciences, Maintains $9 Price Target

BenzingaAug 14 07:00 ET

Caribou Biosciences: A Strong Buy on Solid Financials and Promising Trials

TipRanksAug 14 06:43 ET